The Impact of Drug Interactions on the Results of DAT-SPECT Imaging in a Specialty Movement Disorders Practice: A Retrospective Analysis of Outcomes
Neurodegenerative Diseases · 2024
DOI: 10.1159/000540105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurodegenerative Diseases, 2024. Verfasst von Isabelle Heewon Kang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Tomography, Emission-Computed, Single-Photon, Dopamine Plasma Membrane Transport Proteins, Drug Interactions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Introduction
DAT-SPECT imaging is approved as a diagnostic tool for the evaluation of suspected Parkinsonian syndromes, but the FDA-approved package insert lists 16 potential drugs that may interfere with the image obtained. The clinical impact of these drugs on imaging results has not been established. This study aimed to determine the accuracy of DAT-SPECT imaging in assessing presynaptic dopaminergic denervation in the setting of these drugs.
Methods
This is a retrospective chart review of patients at a single center who underwent DAT-SPECT imaging while taking “contraindicated” drugs between December 2012 and December 2022.
Results
A total of 1,224 charts were screened, and 153 (12.5%) charts met the inclusion criteria. Bupropion (32%, n = 49) and sertraline (26%, n = 40) were the most common contraindicated drugs. The false-positive rate was 9.2%.
Conclusion
This retrospective analysis supports the concern that certain drugs may interfere with DAT-SPECT imaging results, leading to potential false positives. This has implications for how clinicians interpret DAT-SPECT imaging in patients taking these medications and whether they should advise patients to stop these medications before a scan is performed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- The Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Zitieren
APA
Kang, I. H., & Bega, D. (2024). The Impact of Drug Interactions on the Results of DAT-SPECT Imaging in a Specialty Movement Disorders Practice: A Retrospective Analysis of Outcomes. Neurodegenerative Diseases. https://doi.org/10.1159/000540105
Vancouver
Kang IH, Bega D. The Impact of Drug Interactions on the Results of DAT-SPECT Imaging in a Specialty Movement Disorders Practice: A Retrospective Analysis of Outcomes. Neurodegenerative Diseases. 2024. doi:10.1159/000540105
BibTeX
@article{Kang2024,
author = {Kang, Isabelle Heewon and Bega, Danny},
title = {The Impact of Drug Interactions on the Results of DAT-SPECT Imaging in a Specialty Movement Disorders Practice: A Retrospective Analysis of Outcomes},
journal = {Neurodegenerative Diseases},
year = {2024},
doi = {10.1159/000540105}
}
EUVIMED